Cigna Group - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Cigna Group Company

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.

Cigna Group Info



Ticker SymbolCI

Company nameCigna Group

IPO dateApr 01, 1982

CEOMr. David M. Cordani, CPA

Number of employees73500

Security typeOrdinary Share

Fiscal year-endApr 01

Address900 Cottage Grove Road

CityBLOOMFIELD

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code06002

Phone18602266000

Websitehttps://www.thecignagroup.com/

Ticker SymbolCI

IPO dateApr 01, 1982

CEOMr. David M. Cordani, CPA

Company Executives of Cigna Group



Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+1.40%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.52K

-1.63%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+11.66%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+11.66%

Ms. Kimberly A. Ross

Independent Director

4.51K

+16.47%

Mr. George Kurian

Independent Director

3.78K

+20.32%

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+1.40%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.52K

-1.63%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

53.65B

79.86%

Premiums

9.16B

13.63%

Fees and other revenues

4.14B

6.16%

Other revenues

236.00M

0.35%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

53.65B

79.86%

Premiums

9.16B

13.63%

Fees and other revenues

4.14B

6.16%

Other revenues

236.00M

0.35%

Shareholding Stats

Updated: Fri, Aug 15

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.65%

State Street Investment Management (US)

4.59%

MFS Investment Management

3.95%

T. Rowe Price Associates, Inc.

3.71%

Other

73.51%

Shareholders

Proportion

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.65%

State Street Investment Management (US)

4.59%

MFS Investment Management

3.95%

T. Rowe Price Associates, Inc.

3.71%

Other

73.51%

Shareholder Types

Shareholders

Proportion

Investment Advisor

50.49%

Investment Advisor/Hedge Fund

28.66%

Research Firm

2.49%

Hedge Fund

2.38%

Pension Fund

2.31%

Bank and Trust

1.79%

Sovereign Wealth Fund

1.38%

Corporation

1.19%

Individual Investor

0.39%

Other

8.92%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

2904

240.06M

89.93%

-10.15M

2025Q2

2945

245.93M

92.13%

-10.11M

2025Q1

2995

251.66M

94.16%

-8.16M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.89M

2024Q1

2865

261.02M

89.38%

-14.30M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.63M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

25.60M

9.59%

-429.07K

-1.65%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.41M

4.65%

-851.92K

-6.42%

Jun 30, 2025

State Street Investment Management (US)

12.26M

4.59%

-209.47K

-1.68%

Jun 30, 2025

MFS Investment Management

11.41M

4.28%

+104.02K

+0.92%

Jun 30, 2025

T. Rowe Price Associates, Inc.

9.90M

3.71%

-1.75M

-15.05%

Jun 30, 2025

Dodge & Cox

8.95M

3.35%

+60.88K

+0.68%

Jun 30, 2025

Fidelity Management & Research Company LLC

8.81M

3.3%

-1.72M

-16.31%

Jun 30, 2025

Sanders Capital, LLC

7.79M

2.92%

-196.42K

-2.46%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.96M

2.23%

-73.58K

-1.22%

Jun 30, 2025

GQG Partners, LLC

5.77M

2.16%

+883.02K

+18.07%

Jun 30, 2025

Related ETFs



Updated: Mon, Oct 6

Name

Proportion

iShares U.S. Healthcare Providers ETF

4.44%

Invesco Dynamic Buyback Achievers ETF

4.01%

VictoryShares Free Cash Flow ETF

3.45%

Monarch Dividend Plus Index ETF

3.33%

VictoryShares US Multi-Factor Minimum Vol ETF

2.77%

Monarch Volume Factor Dividend Tree Index ETF

2.71%

Davis Select US Equity ETF

2.29%

Brandes US Value ETF

2.29%

Fidelity Blue Chip Value ETF

2.22%

Invesco S&P 500 Enhanced Value ETF

2.07%

iShares U.S. Healthcare Providers ETF

Proportion4.44%

Invesco Dynamic Buyback Achievers ETF

Proportion4.01%

VictoryShares Free Cash Flow ETF

Proportion3.45%

Monarch Dividend Plus Index ETF

Proportion3.33%

VictoryShares US Multi-Factor Minimum Vol ETF

Proportion2.77%

Monarch Volume Factor Dividend Tree Index ETF

Proportion2.71%

Davis Select US Equity ETF

Proportion2.29%

Brandes US Value ETF

Proportion2.29%

Fidelity Blue Chip Value ETF

Proportion2.22%

Invesco S&P 500 Enhanced Value ETF

Proportion2.07%

Dividend



A total of 5.74B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data